AstraZeneca Resolves Most Seroquel Suits for $647 Million

AstraZeneca Plc has settled almost all lawsuits that claimed its antipsychotic drug Seroquel causes diabetes in some users for a total of $647 million.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.